Rethinking Ownership, Stablecoins, and Tokenization from First Principles

Aureon Laboratories

company

About

Aureon Laboratories focused on developing the advancement of predictive and personalized cancer treatment options.

Details

Last Funding Type
Series D
Last Funding Money Raised
$7M
Industries
Biotechnology,Health Diagnostics,Life Science
Founded date
Jan 1, 2001
Operating Status
Active

Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$7M
Aureon Laboratories has raised a total of $7M in funding over 2 rounds. Their latest funding was raised on Apr 14, 2010 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 14, 2010 Series D $7M 1 Detail
Mar 5, 2010 Series C 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Aureon Laboratories is funded by 1 investors. Pfizer are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Series D